Legal & General Group Plc grew its stake in American Healthcare REIT, Inc. (NYSE:AHR – Free Report) by 3.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 914,367 shares of the company’s stock after buying an additional 28,463 shares during the period. Legal & General Group Plc owned approximately 0.57% of American Healthcare REIT worth $33,594,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the stock. Physician Wealth Advisors Inc. bought a new position in shares of American Healthcare REIT in the 2nd quarter valued at approximately $34,000. Avalon Trust Co acquired a new position in American Healthcare REIT during the first quarter valued at approximately $36,000. GAMMA Investing LLC raised its position in shares of American Healthcare REIT by 22.1% in the second quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock valued at $63,000 after purchasing an additional 311 shares during the period. Meeder Asset Management Inc. bought a new position in shares of American Healthcare REIT in the first quarter valued at approximately $97,000. Finally, Grove Bank & Trust acquired a new stake in shares of American Healthcare REIT in the second quarter worth $130,000. Institutional investors own 16.68% of the company’s stock.
American Healthcare REIT Stock Performance
Shares of NYSE AHR opened at $50.49 on Thursday. American Healthcare REIT, Inc. has a one year low of $26.40 and a one year high of $50.80. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $44.59 and a 200 day simple moving average of $40.36. The firm has a market capitalization of $8.93 billion, a price-to-earnings ratio of 360.63, a PEG ratio of 2.03 and a beta of 0.98.
American Healthcare REIT Dividend Announcement
Insider Activity at American Healthcare REIT
In other American Healthcare REIT news, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total transaction of $994,096.80. Following the completion of the transaction, the director directly owned 21,798 shares in the company, valued at $1,082,924.64. This represents a 47.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the transaction, the executive vice president directly owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 25,360 shares of company stock valued at $1,229,398 in the last 90 days. 0.92% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. Royal Bank Of Canada raised their target price on shares of American Healthcare REIT from $45.00 to $54.00 and gave the company an “outperform” rating in a research note on Wednesday, November 12th. Morgan Stanley upped their price target on shares of American Healthcare REIT from $52.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, November 20th. Truist Financial raised their price target on American Healthcare REIT from $46.00 to $53.00 and gave the company a “buy” rating in a research report on Wednesday. UBS Group boosted their price objective on American Healthcare REIT from $51.00 to $56.00 and gave the stock a “buy” rating in a research report on Monday, November 17th. Finally, KeyCorp raised their target price on American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $51.64.
Get Our Latest Analysis on AHR
American Healthcare REIT Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles
- Five stocks we like better than American Healthcare REIT
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Why Gold Loves Trump as Much as Trump Loves Gold
- 3 Tickers Leading a Meme Stock Revival
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Canada Bond Market Holiday: How to Invest and Trade
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
